NSE: THYROCARE | BSE: 539871

Strong Performer, Getting Expensive

Download real time

1193.00 8.65 (0.73%)

New 52W High in past week

60,730 NSE+BSE Volume

NSE 21 Jul, 2025 3:31 PM (IST)

6,322.2

Market Cap

Above industry Median

0.4

Beta 1Year

Very Low volatility

Dividend

Thyrocare Technologies Ltd. has an upcoming dividend of ₹21.00 per share due on 25 Jul 2025 See details

Thyrocare Technologies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for THYROCARE, BSE:539871 Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd.

16 Aug 2016

1193.00

0.73%

Pick of the Week - Thyrocare Technologies Ltd

Buy: Thyrocare Technologies Ltd.

HDFC Securities

BUY Thyrocare Technologies Ltd on Declines Between Rs. 520 - Rs. 490 for the target of Rs. 625 - Rs. 710

Thyrocare Technologies Ltd. has gained 18.13% in the last 1 Month

Thyrocare Technologies Ltd.

27 Apr 2016

1193.00

0.73%

IPO Note - Thyrocare Technologies ltd

IPO Note: Thyrocare Technologies Ltd.

Aditya Birla Money Limited

Strong operating performance and asset light model leading to high returns: The franchise model of the company has helped it to minimize its capital expenditure leading to higher returns on equity as well as return on capital employed. TTL's sales...

Thyrocare Technologies Ltd. has gained 68.36% in the last 3 Months

Thyrocare Technologies Ltd.

27 Apr 2016

1193.00

0.73%

Thyrocare IPO note 27Apr2016

Thyrocare Technologies Ltd.

Phillip Capital

chains. It has a leadership position in (the fastest growing and highest valueadded) diagnosticserviceofferingsinwellnessandpreventivecarethismakesitanindustryleader inprofitability.Weexpectittodeliverrevenue/PATCAGRof25%/29%overFY1518.Atthe...

Promoters released all pledges in Jun 2025 qtr.

Thyrocare Technologies Ltd.

27 Apr 2016

1193.00

0.73%

Thyrocare Technologies IPO Note

Thyrocare Technologies Ltd.

BOB Capital Markets Ltd.

The company is a provider of diagnostic and related healthcare tests and services in India and is specialised in preventive and wellness segment of the diagnostics industry which has broader scope to grow with improving life style...

Promoters released all pledges in Jun 2025 qtr.

Thyrocare Technologies Ltd.

26 Apr 2016

1193.00

0.73%

Thyrocare Technologies Limited

Thyrocare Technologies Ltd.

Angel Broking

Thyrocare Technologies is one of the leading diagnostic chains in India with market share of ~3% amongst organised players. The core business of the company is diagnostic testing (~97.1% of sales as on 9MFY2016) while the company through its wholly owned subsidiary also operates imaging centres. A differentiated model enables higher margi..

Thyrocare Technologies Ltd. has gained 68.36% in the last 3 Months

Is Thyrocare Technologies Ltd. worth buying?

165 Votes:

Buy 76.97%

Sell 12.12%

Hold 10.91%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf